Adverum Biotechnologies
ADVM
ADVM
76 hedge funds and large institutions have $120M invested in Adverum Biotechnologies in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
4.63% less ownership
Funds ownership: 86.07% → 81.45% (-4.6%)
Holders
76
Holding in Top 10
2
Calls
$276K
Puts
$84K
Top Buyers
| 1 | +$2.16M | |
| 2 | +$2.12M | |
| 3 | +$983K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$757K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$738K |
Top Sellers
| 1 | -$4.17M | |
| 2 | -$2.86M | |
| 3 | -$2.83M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.14M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$973K |